NCT07287150
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT07287150
Title A Study to Test Inavolisib Treatment in Participants With Metastatic Castration-Resistant Prostate Cancer (InavoPC)
Acronym InavoPC
Recruitment Recruiting
Gender male
Phase Phase II
Variant Requirements No
Sponsors Hoffmann-La Roche
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | CAN | BRA | AUS

Facility Status City State Zip Country Details
Holden Comprehensive Cancer Center RECRUITING Iowa City Iowa 52242-1009 United States Details
Carolina Urologic Research Center RECRUITING Myrtle Beach South Carolina 29572-4607 United States Details
Sunshine Coast University Hospital RECRUITING Birtinya Queensland 4575 Australia Details
Box Hill Hospital RECRUITING Box Hill Victoria 3128 Australia Details
CEPHO - Centro de Estudos e Pesquisas em Hematologia e Oncologia RECRUITING Santo André São Paulo 09060-650 Brazil Details
Jewish General Hospital RECRUITING Montreal Quebec H3T 1E2 Canada Details
Seoul National University Hospital RECRUITING Seoul 03080 South Korea Details
Severance Hospital, Yonsei University Health System RECRUITING Seoul 03722 South Korea Details
Asan Medical Center. RECRUITING Seoul 05505 South Korea Details
Samsung Medical Center RECRUITING Seoul 06351 South Korea Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field